A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal Cancer
Clinical trial NCT00636610 · COMPLETED
Trial details
- NCT number
- NCT00636610
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2010-12-01
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.